Form 8-K - Current report:
SEC Accession No. 0001213900-26-007330
Filing Date
2026-01-23
Accepted
2026-01-23 17:20:24
Documents
13
Period of Report
2026-01-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0273809-8k_60degrees.htm   iXBRL 8-K 30568
  Complete submission text file 0001213900-26-007330.txt   240812

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sxtp-20260120.xsd EX-101.SCH 3812
3 XBRL DEFINITION FILE sxtp-20260120_def.xml EX-101.DEF 26667
4 XBRL LABEL FILE sxtp-20260120_lab.xml EX-101.LAB 36761
5 XBRL PRESENTATION FILE sxtp-20260120_pre.xml EX-101.PRE 25291
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0273809-8k_60degrees_htm.xml XML 5321
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 26557757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)